Biolab offers STD panel testing for genetic mutations As part of its continued efforts to expand its array of advanced medical tests, Biolab, the exclusive Biomnis dealer in the Kingdom, recently announced that it is now offering a sexually transmitted disease (STD) panel test associated with molecular detection of many sexually transmitted diseases resulting from viruses, bacteria and parasites.

The importance of the STD Panel test is that it serves as a diagnostic tool and indicator in the public health sector and many branches of medicine. As a result, it contributes to the appropriate treatment and combating of many prolific infections.

The STD panel test helps combat more than 25 sexually transmitted diseases that lead to infertility, genital warts, cervical cancer, complications of pregnancy such as premature childbirth, as well as reproductive issues that affect both men and women.

Biolab is a pioneer in applying advances in medicine and science to laboratory testing, providing a broad range of medical diagnostic services to individuals, physicians, hospitals and other laboratories, in addition to offering a wide array of medical, scientific and consultancy services in the fields of health and diagnostics.

Leveraging on cutting-edge technology, high caliber staff and an extensive insurance and bank affiliate network, Biolab offers its patients an unparalleled premium experience, prioritizing reliability, accountability and convenience.